Bone Solutions Inc.

11 articles about Bone Solutions Inc.

• Mg OSTEOINJECT from Bone Solutions Receives 510(k) Clearance for Expanded Indications

  7/13/2022

  Bone Solutions Inc. (BSI), an orthobiologics technology company located in Colleyville, Texas, announced today that it has received FDA 510(k) clearance for expanded indications for its Mg OSTEOINJECT.

• Bone Solutions Inc. Successfully Surpasses 1,000 Implanted Cases with OsteoCrete® Magnesium-Based Bone Void Filler

  2/25/2020

  Bone Solutions Inc., an orthobiologics technology company located in Colleyville, TX, announces it has surpassed 1,000 cases implanting OsteoCrete® in various orthopedic applications.

• Bone Solutions Inc. partners with Onkos Surgical for private label licensing agreement utilizing the OsteoCrete® platform technology

  8/28/2019

  Bone Solutions Inc., announces a private label licensing agreement with Onkos Surgical covering OsteoCrete® technology — the first FDA (510k) cleared magnesium-based bone void filler in the orthopedic marketplace, designed to assist with bone repair and regeneration

• Bone Solutions Inc. Successfully surpasses 500 implanted cases with OsteoCrete® Magnesium-Based Bone Void Filler

  2/26/2019

  Bone Solutions Inc., an orthobiologics technology company located in Colleyville, TX, announces it has surpassed 500 cases implanting OsteoCrete with a 100 % success rate.

• Bone Solutions Inc. Announces New Board Members to support the Company's future growth and development

  10/9/2018

  Bone Solutions Inc. announces three new board members. 

• Bone Solutions Inc. has successfully completed 250 cases with OsteoCrete® Magnesium-Based Bone Void Filler.

  10/2/2018

  Bone Solutions Inc. (BSI), an ortho-biologics technology company announces the first 250 cases of implanted OsteoCrete®.  OsteoCrete® is a Magnesium-based bone void filler is designed to assist with bone repair and generation, and it's the first in the U.S. to incorporate magnesium, a critical property for bone health and development.

• Dallas-Based Bone Solutions Inc. Receives $1.7 Million In Funding

  5/19/2016

• Bone Solutions Inc. Prepares Four Additional FDA Filings for OsteoCrete, Expanding Options for Potential Strategic Partnerships

  5/5/2010

• Bone Solutions Inc. Receives FDA 510(K) Clearance for World's First and Only Magnesium-Based Bone Void Filler, OsteoCrete

  6/8/2009

• Bone Solutions Inc. Appoints Orthopedic Surgeon, Nancy Lynch, M.D., of Scale Venture Partners to its Scientific Advisory Board

  10/20/2008

• Bone Solutions Inc. Appoints Stephen A. Schendel, MD, DDS, Professor Of Plastic And Reconstructive Surgery At Bone Solutions Inc., As Its Chief Medical Officer

  11/14/2006